Femasys FEMY
NASDAQ FEMY
$2.83 +0.15 (+5.60%)
At close: Sep 9, 2026 · 4:00 PM EDT

Femasys (FEMY) Non Operating Income (2020 - 2026)

Femasys' (FEMY) quarterly Non Operating Income came in at $597644.0 in Q2 2026, up 181.38% on a YoY basis from $212394.9 in Q2 2025, and up 181.38% quarter-over-quarter from -$734356.0 in Q2 2025.

Analysis

Femasys (FEMY) Non Operating Income (2020 - 2026) Analysis & Trends

Femasys (FEMY) has reported Non Operating Income for 7 consecutive years, with $597644.0 the latest figure, recorded in Q2 2026.

  • For the quarter ending Q2 2026, Non Operating Income rose 181.38% year-over-year to $597644.0; the trailing twelve-month figure through Jun 2026 stood at -$968050.0 (up 47.81% YoY), and the FY2025 full-year result was -$1.0 million, down 1.64% from the prior year.
  • Non Operating Income climbed to $597644.0 in Q2 2026 per FEMY's latest filing, from -$734356.0 in the prior quarter.
  • Across five years, Non Operating Income topped out at $597644.0 in Q2 2026 and bottomed at -$734356.0 in Q2 2025.
  • Historically, Non Operating Income has averaged -$74688.7 across 5 years, with a median of $25862.0 in 2022.
  • The sharpest annual moves came in 2023 and 2024: Non Operating Income soared 34177.5% in 2023, then slumped 1000.75% in 2024.
  • Over 5 years, Non Operating Income stood at $112466.0 in 2022, then sank by 61.41% to $43399.0 in 2023, then plunged by 1000.75% to -$390918.0 in 2024, then tumbled by 87.85% to -$734356.0 in 2025, then jumped by 181.38% to $597644.0 in 2026.
  • According to Business Quant data, Non Operating Income over the past three periods registered $597644.0, -$734356.0, and -$440420.0 for Q2 2026, Q2 2025, and Q1 2025 respectively.
Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Non Op. Inc. (Qtr)
1 Abbott Laboratories 187.42 Bn 182.47 Bn 7.27 Bn -
2 Intuitive Surgical 129.78 Bn 124.69 Bn 1.96 Bn 82.70 Mn
3 Medtronic 120.53 Bn 112.33 Bn 6.34 Bn -
4 Stryker 116.28 Bn 112.80 Bn 4.50 Bn 46.00 Mn
5 Boston Scientific 69.29 Bn 68.99 Bn 3.85 Bn -
6 Edwards Lifesciences 51.83 Bn 47.68 Bn 1.35 Bn 6.60 Mn
7 Alcon 34.36 Bn 32.91 Bn 1.68 Bn -
8 Dexcom 33.17 Bn 31.23 Bn 830.00 Mn -
9 Steris 21.90 Bn 21.43 Bn 684.20 Mn -12.30 Mn
10 Femasys 9.01 Mn 7.57 Mn 189,391.00 597,644.00
Historic Data

Historic Data

Download Data
DateValue
Jun 30, 2026 597,644.00
Jun 30, 2025 -734,356.00
Mar 31, 2025 -440,420.00
Dec 31, 2024 -390,918.00
Sep 30, 2024 -289,262.00
Jun 30, 2024 -204,173.00
Mar 31, 2024 -136,868.00
Dec 31, 2023 43,399.00
Sep 30, 2023 84,359.00
Jun 30, 2023 42,454.00
Mar 31, 2023 95,417.00
Dec 31, 2022 112,466.00
Sep 30, 2022 74,346.00
Jun 30, 2022 25,862.00
Mar 31, 2022 -280.00
Dec 31, 2021 -3,117.00
Sep 30, 2021 -8,256.00
Jun 30, 2021 818,016.00
Dec 31, 2020 6,746.00
Sep 30, 2020 -3,418.00